Viking Therapeutics (VKTX) EPS (Basic): 2014-2025
Historic EPS (Basic) for Viking Therapeutics (VKTX) over the last 12 years, with Sep 2025 value amounting to -$0.81.
- Viking Therapeutics' EPS (Basic) fell 268.18% to -$0.81 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.12, marking a year-over-year decrease of 127.96%. This contributed to the annual value of -$1.01 for FY2024, which is 10.99% down from last year.
- According to the latest figures from Q3 2025, Viking Therapeutics' EPS (Basic) is -$0.81, which was down 39.66% from -$0.58 recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' EPS (Basic) registered a high of -$0.16 during Q4 2021, and its lowest value of -$0.81 during Q3 2025.
- For the 3-year period, Viking Therapeutics' EPS (Basic) averaged around -$0.34, with its median value being -$0.25 (2023).
- As far as peak fluctuations go, Viking Therapeutics' EPS (Basic) grew by 17.39% in 2023, and later plummeted by 268.18% in 2025.
- Viking Therapeutics' EPS (Basic) (Quarterly) stood at -$0.16 in 2021, then slumped by 62.50% to -$0.26 in 2022, then increased by 3.85% to -$0.25 in 2023, then fell by 28.00% to -$0.32 in 2024, then slumped by 268.18% to -$0.81 in 2025.
- Its EPS (Basic) was -$0.81 in Q3 2025, compared to -$0.58 in Q2 2025 and -$0.41 in Q1 2025.